LDL-CHOLESTEROL LOWERING WITH ATORVASTATIN, ROSUVASTATIN AND SIMVASTATIN: RESULTS OF A RETROSPECTIVE OBSERVATIONAL STUDY.
Rosuvastatin and atorvastatin were associated with greater LDL-cholesterol reduction compared with simvastatin in primary health care. Combination therapy with ezetimibe significantly increased the likelihood of achieving therapeutic LDL targets.
Authors
- Arieta Hasani Alidema (ORCID: https://orcid.org/0009-0004-0989-1900)
- Mirlinda Havolli
- Fellenza Abazi
- F Alidema
- L Mustafa
Institutions
- University of Maribor (SI)
- University for Business and Technology (XK)
Publication Details
- Journal
- PubMed
- Published
- 2025-12-01
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00